MO HB1717

Veterans and first responders aged 21+ with PTSD, major depressive disorder, substance use disorders, or requiring end-of-life care may legally use psilocybin for therapeutic purposes if enrolled in a study, supervised by a qualified facilitator, and limited to 150 milligrams per 12-month period

Qualified facilitators must be licensed healthcare professionals (physicians, psychologists, clinical social workers, nurse practitioners, etc.) who have completed at least 30 hours of psilocybin-specific training consistent with American Psychological Association or American Psychedelic Practitioners Association guidelines

Department of Mental Health shall provide $2 million in grants for psilocybin research and conduct a study on psilocybin efficacy for treating veterans with PTSD, depression, substance use disorders, or end-of-life needs

Expands Missouri's existing "Right to Try" law to include patients with life-threatening or severely debilitating conditions (previously limited to terminal illness) and removes the exclusion of Schedule I controlled substances from investigational treatments

Provides legal immunity from state criminal/civil liability for physicians, healthcare providers, facilitators, and laboratories involved in authorized psilocybin therapy, and prohibits disclosure of participant information to federal authorities